Results 291 to 300 of about 10,318 (317)

GLP-1RA associated with diabetic retinopathy?

Reactions Weekly, 2019
openaire   +1 more source

Bariatrische Operation versus GLP-1RA

Diabetologie und Stoffwechsel
openaire   +1 more source

GLP-1RAs may cause intolerable gastrointestinal AEs

Reactions Weekly, 2023
openaire   +1 more source

GLP-1RA, SGLT2i und Amputationsrisiko

Diabetologie und Stoffwechsel
openaire   +1 more source

Empagliflozin/Finerenon plus GLP-1RA

Diabetologie und Stoffwechsel
openaire   +1 more source

Impact of GLP ‐ 1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol‐Associated Liver Disease and Type 2 Diabetes

Liver International
Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil   +2 more
exaly  

GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment

Gastroenterology Insights
Caesar Ferrari, Micheal Tadros
exaly  

Walking Further with GLP-1RAs: Lessons from the STRIDE Trial

The International Journal of Lower Extremity Wounds
Dimitrios Pantazopoulos, Stella Papachristou, Prashanth R J Vas, Nikolaos Papanas   +3 more
openaire   +2 more sources

Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020

Current Medical Research and Opinion
Benjamin G Mittman, Michael B Rothberg
exaly  

Combination Therapy of Endoscopic Gastric Remodeling with GLP-1RA for the Treatment of MASLD

Obesity Surgery
Pichamol Jirapinyo, Aunchalee Jaroenlapnopparat, Christopher C Thompson   +2 more
exaly